Results 101 to 110 of about 32,586 (241)
Novel mutation associated with non‐compaction ventricular myocardium: A case report
ESC Heart Failure, Volume 12, Issue 6, Page 4548-4554, December 2025.
Yan Li +4 more
wiley +1 more source
The role of a malignancy in the treatment of a venous thromboembolism and superficial thrombophlebitis [PDF]
, 2017 Cancer patients have a manifold risk of suffering from both thrombotic events and anticoagulation-related bleeding complications. For this reason, knowledge of their adequate medication is crucial.
Taanila, Anette
core
PLoS ONE, 2018 Background Venous thromboembolism (VTE) is a major global cause of morbidity and mortality. Low molecular weight heparin (LMWH) and fondaparinux (FDP) are frequently used to treat and prevent VTE and have a variety of safety and practical advantages over
A. Johnston +6 more
semanticscholar +1 more source
FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME
Российский кардиологический журнал, 2015 Anticoagulation treatment is a vital component of acute coronary syndrome treatment. Selection of the most efficient and safe drug for the acute coronary syndrome patients without ST elevation (NSTEACS) depends on the strategy of treatment and is in fact
G. V. Mardaryan, S. A. Abugov
doaj +1 more source
Estudio comparativo entre el Fondaparinux y la Nadroparina en la prevención del tromboembolismo venoso tras artroplastias de rodillas [PDF]
, 2005 El fondaparinux pertenece a una nueva clase de agentes antitrombóticos, los inhibidores selectivos del factor Xa. Nuestro estudio se propone analizar las diferencias entre las complicaciones originadas por la utilización de fondaparinux sódico y una ...
Gava, R., Hernández Vaquero, Daniel
core
Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients. [PDF]
, 2012 SummaryAnticoagulation therapy for the prevention of venous thromboembolic events is indicated in patients after major orthopaedic surgery and in hospitalised acutely ill medical patients, who have a high or moderate risk of venous thromboembolism (VTE),
Ageno W, Spyropoulos AC, Turpie AG
core +1 more source
Management of anticoagulant-related intracranial hemorrhage: An evidence-based review [PDF]
, 2014 The increased use of anticoagulants for the prevention and treatment of thromboembolic diseases has led to a rising incidence of anticoagulant-related intracranial hemorrhage (AICH) in the aging western population. High mortality accompanies this form of
Keyrouz, Salah G, Ray, Bappaditya
core +3 more sources
Arquivos Brasileiros de Cardiologia, 2012 FUNDAMENTO: O uso combinado de agentes antitrombínicos, antiplaquetários e estratégias invasivas na síndrome coronariana aguda sem supradesnivelamento do ST (SCAsSST) reduz eventos cardiovasculares. O fondaparinux demonstrou equivalência à enoxaparina na
Camila Pepe +3 more
doaj
Global Spine Journal, 2019 Study Design: Retrospective cohort study. Objective: To assess the impact of fondaparinux on venous thromboembolism (VTE) following elective lumbar spine surgery in high-risk patients. Methods: Matched patient cohorts who did or did not receive inpatient
Mitchell S. Fourman +8 more
semanticscholar +1 more source
Evaluation of bleeding risk in patients with renal impairment treated with Fondaparinux (Arixtra)
Journal of Applied Hematology, 2016 Background: Fondaparinux (Arixtra) a synthetic pentasaccharide that causes an antithrombin III-mediated selective inhibition of factor Xa. The clearance of fondaparinux reduces in patients with renal impairment, and there are no dosage adjustments ...
Hend H Metwali +6 more
doaj +1 more source